These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem. Goldman RC Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model. Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471 [TBL] [Abstract][Full Text] [Related]
10. Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility. Jain P; Garing S; Verma D; Saranathan R; Clute-Reinig N; Gadwa J; Peterson C; Hermansky G; Astashkina Fernandez A; Asare E; Weisbrod TR; Spencer E; Mulholland CV; Berney M; Bell D; Nichols KP; Le Ny AM; Ordway D; Jacobs WR; Somoskovi A; Minch KJ J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32900827 [TBL] [Abstract][Full Text] [Related]
11. Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model. Sarkar S; Sarkar D J Biomol Screen; 2012 Aug; 17(7):966-73. PubMed ID: 22573731 [TBL] [Abstract][Full Text] [Related]
12. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis. Gold B; Warrier T; Nathan C Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324 [TBL] [Abstract][Full Text] [Related]
13. Novel red fluorescence protein based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffin. Yeware A; Sarkar D Tuberculosis (Edinb); 2018 May; 110():15-19. PubMed ID: 29779767 [TBL] [Abstract][Full Text] [Related]
14. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G. Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226 [TBL] [Abstract][Full Text] [Related]
15. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862 [TBL] [Abstract][Full Text] [Related]
16. Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening. Scharf NT; Molodtsov V; Kontos A; Murakami KS; Garcia GA SLAS Discov; 2017 Mar; 22(3):287-297. PubMed ID: 28027449 [TBL] [Abstract][Full Text] [Related]
17. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages. Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663 [TBL] [Abstract][Full Text] [Related]
18. A high throughput methodology for susceptibility testing of Mycobacterium tuberculosis isolates. Rampersad T; Makume M; Sobia P; Willem Sturm A J Microbiol Methods; 2018 Mar; 146():64-67. PubMed ID: 29410256 [TBL] [Abstract][Full Text] [Related]
19. Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening. Kumar A; Chettiar S; Brown BS; Early J; Ollinger J; Files M; Bailey MA; Korkegian A; Dennison D; McNeil M; Metz J; Osuma A; Curtin M; Kunzer A; Freiberg G; Bruncko M; Kempf D; Parish T Sci Rep; 2022 Sep; 12(1):14879. PubMed ID: 36050506 [TBL] [Abstract][Full Text] [Related]
20. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery. Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]